Lorcaserin Effects on Cocaine Craving and Drug-Reinforced Behavior
氯卡色林对可卡因渴望和药物强化行为的影响
基本信息
- 批准号:8684554
- 负责人:
- 金额:$ 18.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgonistAngerAnimalsAttenuatedBasal GangliaBehaviorBehavioralBiological AssayBiological AvailabilityBody Weight decreasedBrainBrain StemCYP2D6 geneCell NucleusCell RespirationClinical ResearchCocaineCocaine AbuseCocaine UsersComplexCuesCytochrome P450DiseaseDopamineDoseDouble-Blind MethodDrug KineticsDrug usageEconomicsEmotionalEnzymesEvaluationEventExhibitsExposure toFDA approvedFluoxetineFoodG-Protein-Coupled ReceptorsGenetic Crossing OverGoalsGuided imageryHealthHeart Valve DiseasesHepaticHumanHypothalamic structureIndividualInfusion proceduresInjection of therapeutic agentIntravenousIntravenous infusion proceduresLaboratoriesLaboratory AnimalsLightMeasuresMedicalMemoryMetabolismMethodsMotor ActivityNeuronsNeurotransmittersOralParticipantPatientsPharmaceutical PreparationsPlacebo ControlPlacebosPlasmaPlayPropertyPsychostimulant dependenceRandomizedRattusRelative (related person)ReportingResearchRoleSafetySamplingSelf AdministrationSelf-AdministeredSerotoninStimulusStructureTryptophanUnited StatesVeinsactive methodbasecocaine usecravingdisorder later incidence preventiondrug abuse preventiondrug cravingdrug of abusedrug seeking behaviorexperiencefrontal lobehuman subjectinhibitor/antagonistmonoaminemotivated behaviornovelobesity treatmentpreclinical studypublic health relevanceraphe nucleireceptorreinforced behaviorsocialsoundsubstance abuse treatment
项目摘要
DESCRIPTION (provided by applicant): Background Serotonin (5-HT) is one of three monoamines that are widely distributed in the brain and play important roles in affect and goal-directed behaviors. Limbic structures that underlie behavior motivated by palatable food and drugs of abuse receive dense projections from brainstem serotonergic nuclei. In rats, light and sound cues associated with access to cocaine strongly stimulate drug-seeking behavior. Agonists for the type 2C serotonergic receptor (5-HT2CR) attenuate this responding. Drug taking (cocaine self-administration) is also attenuated at 5-HT2CR agonist doses similar to those that decrease food-reinforced responding and cause reductions in locomotor activity. Lorcaserin is a novel and selective agonist of the 5-HT2CR recently approved by the FDA for weight loss therapy. It acts selectively at this receptor subtype with minimal activation of 5-HT2AR or 5-HT2BR receptors. Based on initial clinical studies leading to its approval, lorcaserin is well tolerated and probably does not cause cardiac valve disease or other serious side effects. Rationale In preclinical studies, agonists for the 5-HT2CR potently attenuate cocaine-seeking behavior. Lorcaserin is a recently approved selective 5-HT2CR agonist with an acceptable safety profile in humans. No studies have reported its effects on cocaine-induced craving or drug-reinforced responding in humans. Specific Aims: 1. Determine whether lorcaserin pretreatment attenuates the positive subjective effects of cocaine and drug- reinforced behavior. 2. Evaluate whether active treatment modifies cocaine- or script- induced craving. 3. Characterize the bioavailability of lorcaserin in individual participants and determine
whether it modifies plasma levels of cocaine. Methods This is a randomized, cross-over, double-blind, placebo-controlled, research-unit, single-center, multiple-panel evaluation of the potential
for oral lorcaserin to modify craving and cocaine self-administration in a laboratory setting. A total of 24 non-treatment-seeking, regular cocaine users will receive pretreatment with single doses of oral placebo, lorcaserin 10 mg (panel 1), or lorcaserin 20 mg (panel 2). Script-guided imagery of autobiographical memories will be developed based on experiences related to cocaine use, anger, and a neutral event. Following treatment with lorcaserin, script-induced emotional states will be assayed. Sampling doses of cocaine (0.0, 0.23, and 0.46 mg/kg) will be administered, and participants will choose between self- administering additional intravenous doses or receiving monetary alternatives. Detailed measures of the negative and positive subjective effects of intravenous infusions will also be made. As noncontingent infusions of cocaine are administered, the pharmacokinetics of cocaine and lorcaserin will be determined.
背景5-羟色胺(5-HT)是大脑中广泛分布的三种单胺之一,在情感和目标导向行为中发挥重要作用。支持受美味食物和药物滥用的行为的边缘结构从脑干5-羟色胺能核接受密集的投射。在老鼠身上,与可卡因接触相关的光和声音线索强烈地刺激了寻找毒品的行为。2C型5-羟色胺能受体(5-HT2CR)激动剂可减弱这种反应。服药(可卡因自身给药)在5-HT2CR激动剂剂量下也会减弱,类似于那些降低食物强化反应和导致运动活动减少的药物。氯卡瑟林是FDA最近批准用于减肥治疗的5-HT2CR的一种新型选择性激动剂。它选择性地作用于这个受体亚型,最小限度地激活5-HT2AR或5-HT2BR受体。根据导致其获得批准的初步临床研究,氯卡色林耐受性良好,可能不会导致心脏瓣膜疾病或其他严重的副作用。在临床前研究中,5-HT2CR的激动剂有效地减弱了寻求可卡因的行为。氯卡瑟林是最近批准的一种选择性5-HT2CR激动剂,在人类中具有可接受的安全性。还没有研究报告它对可卡因诱导的欲望或人类的药物强化反应的影响。具体目的:1.确定氯酪蛋白预处理是否减弱可卡因的积极主观效应和药物强化行为。2.评估积极治疗是否能改变可卡因或剧本引发的渴望。3.确定氯酪蛋白在个体参与者体内的生物利用度,并确定
它是否会改变血浆中可卡因的水平。方法这是一项随机、交叉、双盲、安慰剂对照、研究单位、单中心、多小组的潜力评估。
用于在实验室环境下口服氯酪蛋白来改善饥饿感和可卡因自我给药。共有24名不寻求治疗的常规可卡因使用者将接受单剂量口服安慰剂、氯卡韦林10毫克(第一组)或氯卡斯林20毫克(第二组)的预治疗。自传体记忆的剧本引导图像将基于与可卡因使用、愤怒和中性事件相关的经验而开发。在使用氯卡瑟林治疗后,将分析脚本诱导的情绪状态。将给予抽样剂量的可卡因(0.0、0.23和0.46毫克/公斤),参与者将在自我注射额外的静脉剂量或接受货币替代品之间进行选择。还将对静脉输液的消极和积极的主观影响进行详细的测量。随着非偶然输注可卡因的实施,可卡因和氯酪蛋白的药代动力学将被确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH W. GRASING其他文献
KENNETH W. GRASING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH W. GRASING', 18)}}的其他基金
Translating Melatonin- and Serotonin-2C Interactions into Improved Treatments for Pain and Opioid-Use Disorders
将褪黑素和血清素 2C 的相互作用转化为疼痛和阿片类药物使用障碍的改进治疗方法
- 批准号:
10515318 - 财政年份:2019
- 资助金额:
$ 18.75万 - 项目类别:
Translating Melatonin- and Serotonin-2C Interactions into Improved Treatments for Pain and Opioid-Use Disorders
将褪黑素和血清素 2C 的相互作用转化为疼痛和阿片类药物使用障碍的改进治疗方法
- 批准号:
10045505 - 财政年份:2019
- 资助金额:
$ 18.75万 - 项目类别:
Translating Melatonin- and Serotonin-2C Interactions into Improved Treatments for Pain and Opioid-Use Disorders
将褪黑素和血清素 2C 的相互作用转化为疼痛和阿片类药物使用障碍的改进治疗方法
- 批准号:
10292939 - 财政年份:2019
- 资助金额:
$ 18.75万 - 项目类别:
Lorcaserin Effects on Cocaine Craving and Drug-Reinforced Behavior
氯卡色林对可卡因渴望和药物强化行为的影响
- 批准号:
8918564 - 财政年份:2014
- 资助金额:
$ 18.75万 - 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
- 批准号:
8244379 - 财政年份:2012
- 资助金额:
$ 18.75万 - 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
- 批准号:
8774152 - 财政年份:2012
- 资助金额:
$ 18.75万 - 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
- 批准号:
8598009 - 财政年份:2012
- 资助金额:
$ 18.75万 - 项目类别:
Persistent Attenuation of Cocaine-Reinforced Behavior
可卡因强化行为的持续减弱
- 批准号:
8413391 - 财政年份:2012
- 资助金额:
$ 18.75万 - 项目类别:
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetic Measures
他克林对可卡因自我给药的影响和药代动力学测量
- 批准号:
8278546 - 财政年份:2011
- 资助金额:
$ 18.75万 - 项目类别:
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetic Measures
他克林对可卡因自我给药的影响和药代动力学测量
- 批准号:
8113822 - 财政年份:2011
- 资助金额:
$ 18.75万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 18.75万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Studentship